GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 77 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $389,000 | -77.7% | 7,400 | -77.5% | 0.03% | -66.7% |
Q1 2019 | $1,741,000 | -62.5% | 32,900 | -65.8% | 0.08% | -72.7% |
Q1 2018 | $4,646,000 | +550.7% | 96,200 | +318.3% | 0.30% | +681.6% |
Q3 2017 | $714,000 | +13.5% | 23,000 | 0.0% | 0.04% | -2.6% |
Q2 2017 | $629,000 | +50.1% | 23,000 | -20.7% | 0.04% | +14.7% |
Q4 2016 | $419,000 | -71.8% | 29,000 | -55.0% | 0.03% | -71.7% |
Q3 2016 | $1,484,000 | -41.9% | 64,400 | -58.2% | 0.12% | -49.8% |
Q2 2016 | $2,554,000 | +77.9% | 154,000 | +70.0% | 0.24% | +64.8% |
Q1 2016 | $1,436,000 | +0.8% | 90,600 | +105.4% | 0.14% | -20.3% |
Q4 2015 | $1,425,000 | – | 44,100 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |